Precision BioSciences, Inc. (DTIL)
9.87
+1.75
(+21.55%)
USD |
NASDAQ |
Nov 05, 16:00
9.80
-0.07
(-0.71%)
After-Hours: 07:39
Precision BioSciences Total Liabilities (Quarterly) : 68.60M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 68.60M |
| June 30, 2026 | 80.63M |
| March 31, 2026 | 67.79M |
| December 31, 2025 | 62.17M |
| September 30, 2025 | 76.88M |
| June 30, 2025 | 74.87M |
| March 31, 2025 | 75.07M |
| December 31, 2024 | 80.00M |
| September 30, 2024 | 88.39M |
| June 30, 2024 | 91.09M |
| March 31, 2024 | 147.54M |
| December 31, 2023 | 140.92M |
| September 30, 2023 | 135.28M |
| June 30, 2023 | 147.66M |
| March 31, 2023 | 164.32M |
| December 31, 2022 | 177.74M |
| September 30, 2022 | 187.35M |
| June 30, 2022 | 194.14M |
| Date | Value |
|---|---|
| March 31, 2022 | 111.69M |
| December 31, 2021 | 120.33M |
| September 30, 2021 | 125.76M |
| June 30, 2021 | 129.56M |
| March 31, 2021 | 203.49M |
| December 31, 2020 | 105.73M |
| September 30, 2020 | 104.86M |
| June 30, 2020 | 98.59M |
| March 31, 2020 | 99.17M |
| December 31, 2019 | 96.92M |
| September 30, 2019 | 104.51M |
| June 30, 2019 | 97.94M |
| March 31, 2019 | 155.97M |
| December 31, 2018 | 98.64M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 99.05M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 81.70B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 988.45M |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 120.38M |
| Shareholders Equity (Quarterly) | 51.78M |
| Debt to Equity Ratio | 0.5354 |
| Current Ratio | 10.47 |
| Net Debt Paydown Yield | 0.20% |